Nipple Discharge: Drugs That Cause It and Drugs That Treat It

Why Medications Cause Nipple Discharge

Prolactin is the primary hormone behind milk production. Any drug that blocks dopamine receptors in the tuberoinfundibular pathway or depletes dopamine stores can lift prolactin levels and trigger galactorrhea, the medical term for milky nipple discharge unrelated to breastfeeding. The mechanism is straightforward: dopamine normally suppresses prolactin release from the anterior pituitary, so blocking that brake lets prolactin climb 1.

Drug-induced hyperprolactinemia is not rare. A 2004 review in the Journal of Clinical Psychopharmacology estimated that antipsychotic-associated prolactin elevation occurs in 40-90% of patients depending on the agent, with galactorrhea reported in 10-50% of women taking conventional antipsychotics 2. Men can also develop galactorrhea, though it occurs less frequently because breast tissue requires estrogen priming.

The discharge itself is usually bilateral, expressible rather than spontaneous, and milky or clear. It is painless. These features distinguish it from pathologic discharge, which tends to be unilateral, spontaneous, and sometimes bloody.

Antipsychotics: The Biggest Offenders

First-generation (typical) antipsychotics such as haloperidol, chlorpromazine, and fluphenazine are potent D2 blockers, and all of them raise prolactin predictably. Among second-generation agents, risperidone and paliperidone stand out. Risperidone elevates prolactin in up to 70-90% of patients, with mean levels reaching 45-80 ng/mL in women, far above the normal ceiling of approximately 25 ng/mL 3.

Not all atypical antipsychotics carry equal risk. Aripiprazole, a partial D2 agonist, actually lowers prolactin. Quetiapine and clozapine cause only transient, modest elevations 4. This pharmacologic difference makes aripiprazole a common switch target when a patient develops galactorrhea on another antipsychotic.

A practical hierarchy of antipsychotic prolactin risk, from highest to lowest: risperidone and paliperidone sit at the top, followed by haloperidol and first-generation phenothiazines, then olanzapine and ziprasidone (moderate risk), and finally quetiapine, clozapine, and aripiprazole at the bottom.

Other Drug Classes That Trigger Galactorrhea

Antipsychotics get the most attention, but several other medication categories can raise prolactin enough to produce nipple discharge.

Gastrointestinal prokinetics. Metoclopramide and domperidone are D2 antagonists marketed for gastroparesis and nausea. Metoclopramide raises prolactin in a dose-dependent fashion. A study in Alimentary Pharmacology & Therapeutics found that 10 mg three times daily doubled or tripled baseline prolactin in most subjects within one week 5. Galactorrhea is listed as a recognized side effect in the FDA label.

Antidepressants. SSRIs, particularly sertraline and fluoxetine, can cause mild prolactin elevations through serotonin-mediated stimulation of prolactin-releasing factors. Clinically significant galactorrhea from SSRIs is uncommon but documented in case series 6. Tricyclic antidepressants, especially amitriptyline, carry a similar low-frequency risk.

Antihypertensives. Verapamil, a calcium-channel blocker, is uniquely associated with galactorrhea among cardiac medications. It appears to reduce hypothalamic dopamine activity. Case reports document prolactin levels of 40-60 ng/mL in patients taking 240-480 mg daily 7.

Opioids. Chronic opioid use suppresses the hypothalamic-pituitary-gonadal axis and raises prolactin. A 2010 study in The Journal of Clinical Endocrinology & Metabolism found that prolactin levels were elevated in 15-20% of men on long-term opioid therapy 8.

Estrogen-containing medications. Oral contraceptive pills and postmenopausal hormone therapy can cause galactorrhea through direct stimulation of breast tissue, though prolactin levels often remain within normal limits.

Drug-Induced Galactorrhea vs. Other Causes of Nipple Discharge

Not all nipple discharge is galactorrhea, and not all galactorrhea is drug-related. A systematic approach matters.

Bilateral milky discharge in a premenopausal woman is galactorrhea until proven otherwise. The 2011 Endocrine Society Clinical Practice Guideline on hyperprolactinemia recommends checking a serum prolactin level as the first step 9. Dr. Shlomo Melmed, lead author of the guideline, wrote: "Drug-induced hyperprolactinemia should always be considered before pursuing pituitary imaging, as it is the most common cause of non-physiologic hyperprolactinemia."

If prolactin is elevated and the patient takes a medication known to raise it, the diagnostic path typically involves a supervised medication withdrawal or switch. If prolactin normalizes within 72 hours of stopping the drug, drug causation is confirmed 9.

Unilateral, spontaneous, bloody, or serous discharge follows a different algorithm. This pattern warrants breast imaging (mammography and/or ultrasound) and possible ductography or biopsy. Intraductal papilloma is the most common benign cause of bloody nipple discharge, accounting for roughly 35-48% of cases in surgical series 10. Ductal carcinoma in situ represents the malignant end of the spectrum, present in 5-21% of patients referred for pathologic discharge 10.

How Clinicians Diagnose the Cause

The workup for nipple discharge follows a structured sequence. A detailed medication history is the single most important first step, because drug-induced galactorrhea can be resolved without imaging or invasive testing.

Serum prolactin. Drawn fasting and ideally before noon. Values above 200 ng/mL strongly suggest a prolactinoma rather than drug effect, as most medications push prolactin to the 25-100 ng/mL range 9. The Endocrine Society guideline notes that prolactin levels above 250 ng/mL are "virtually diagnostic of a macroprolactinoma."

Thyroid function. Hypothyroidism raises TRH, which stimulates prolactin release. A TSH level rules this out efficiently.

Pregnancy test. Pregnancy is the most common physiologic cause of galactorrhea in reproductive-age women.

MRI of the pituitary. Indicated when prolactin is elevated and drug causation has been excluded, or when prolactin exceeds 100 ng/mL even in the setting of a suspect medication. Microprolactinomas (<10 mm) are found in roughly 10% of the general population at autopsy, though most are clinically silent 11.

Breast imaging. Reserved for unilateral, spontaneous, or bloody discharge. A 2017 meta-analysis in Radiology found that MRI had 92% sensitivity for detecting malignancy in patients with pathologic nipple discharge 12.

Dopamine Agonists: The First-Line Drug Treatment

When nipple discharge stems from hyperprolactinemia, whether drug-induced or caused by a prolactinoma, dopamine agonists are the primary pharmacologic treatment.

Cabergoline (Dostinex) is the preferred agent. It binds D2 receptors on pituitary lactotroph cells, suppressing prolactin synthesis and secretion. A landmark 1994 comparative trial in The New England Journal of Medicine (N=459) found that cabergoline normalized prolactin in 83% of women with hyperprolactinemic amenorrhea/galactorrhea, compared with 59% for bromocriptine 13. The standard starting dose is 0.25 mg twice weekly, titrated up based on prolactin response.

Cabergoline has a long half-life of 63-69 hours, allowing twice-weekly dosing. Side effects include nausea (27%), headache (26%), and dizziness (17%), but they are generally milder and less frequent than with bromocriptine 13.

Bromocriptine (Parlodel) was the first dopamine agonist approved for galactorrhea (FDA approval, 1978). Effective, but less well-tolerated. Typical dosing starts at 1.25 mg at bedtime and increases to 2.5-7.5 mg daily in divided doses. Nausea, orthostatic hypotension, and nasal congestion are common early complaints. Bromocriptine remains the preferred choice in women planning pregnancy, because the safety database in pregnancy is larger (over 6,000 reported pregnancies) compared with cabergoline (approximately 900) 14.

Response is typically rapid. Galactorrhea resolves within 2-4 weeks of achieving prolactin normalization in most patients.

Managing Drug-Induced Galactorrhea Without Stopping the Causative Drug

Sometimes the medication causing galactorrhea cannot be discontinued. A patient with treatment-resistant schizophrenia who responds only to risperidone, for example, may not tolerate a switch.

Three strategies exist for this scenario. The first is dose reduction of the offending agent, if clinically safe. Even modest reductions can lower prolactin meaningfully. The second is augmentation with aripiprazole. A 2008 randomized controlled trial (N=56) published in The Journal of Clinical Psychiatry showed that adding aripiprazole 15 mg/day to risperidone reduced mean prolactin from 96.4 ng/mL to 19.7 ng/mL within 8 weeks, a 79.6% decrease 15. Galactorrhea resolved in all affected participants by week 8.

The third option is adding a low-dose dopamine agonist. Cabergoline 0.25-0.5 mg weekly can counteract antipsychotic-induced prolactin elevation, though clinicians must monitor for potential worsening of psychotic symptoms, since dopamine agonism opposes the antipsychotic's mechanism. A 2012 review in Psychoneuroendocrinology reported that low-dose cabergoline did not worsen psychosis in the small studies available, but called for larger trials 16.

Treating Pathologic Nipple Discharge: Surgical and Procedural Options

When nipple discharge is pathologic (spontaneous, unilateral, bloody) and imaging identifies a structural lesion, treatment is typically surgical.

Microdochectomy (single-duct excision) removes the offending duct and any associated papilloma. Success rates for resolving discharge exceed 90% in published series 17. It is the standard procedure when cytology or imaging localizes the lesion to a single duct.

Central duct excision (Hadfield procedure) removes all major subareolar ducts. It is appropriate when discharge arises from multiple ducts, when the offending duct cannot be identified, or in cases of recurrent discharge after single-duct surgery.

For malignant causes (DCIS or invasive carcinoma discovered during workup), treatment follows standard oncologic protocols including surgery, radiation, and/or endocrine therapy as indicated by staging and receptor status.

When Nipple Discharge Needs No Treatment at All

Many cases require only reassurance. Bilateral, milky, expressible discharge in a premenopausal woman with normal prolactin and no other symptoms is physiologic galactorrhea. It resolves with cessation of nipple stimulation (including self-examination) in most cases 18. The American College of Obstetricians and Gynecologists states: "Physiologic discharge that is bilateral, involves multiple ducts, and is non-bloody does not require further evaluation beyond clinical breast examination" 18.

Green or dark discharge from multiple ducts usually indicates fibrocystic changes or duct ectasia, both benign. No pharmacologic treatment is needed.

Clear or serous discharge from a single duct warrants investigation, but the majority of causes are still benign.

Special Populations: Men and Postmenopausal Women

Nipple discharge in men is uncommon and always warrants investigation. The differential includes prolactinoma, drug-induced hyperprolactinemia (antipsychotics are the leading cause), breast cancer (1% of all breast cancers occur in men), and liver cirrhosis with hyperestrogenism 19.

In postmenopausal women, any nipple discharge is considered pathologic until proven otherwise. The risk of an underlying malignancy is higher than in premenopausal women. A 2006 retrospective study of 618 women with nipple discharge found that the malignancy rate was 3% in premenopausal women versus 16% in postmenopausal women 20. Mammography and, in many centers, breast MRI are standard first-line imaging in this group.

The initial laboratory workup is the same: prolactin, TSH, and a complete medication review. If a drug is responsible and switching is possible, galactorrhea resolves with the same dopamine agonist protocols used in younger patients.